Additional Therapy with a Mistletoe Product during Adjuvant Chemotherapy of Breast Cancer Patients Improves Quality of Life: An Open Randomized Clinical Pilot Trial

Figure 3

Differences of the mean of six follow-up values to baseline of the EORTC QLQ-C30 symptom scores (mean ± sd) sorted by group differences. All patients with at least one follow-up visit are displayed. 𝑃 values are corrected using Bonferroni’s method regarding 15 EORTC scores tested and defined as follows: ***𝑃<0.001 (extremely significant); **𝑃<0.01 (highly significant); *𝑃<0.05 (significant); n.s.: not significant.